Aurora Cannabis (TSE:ACB) Shares Up 9.9% – Should You Buy?

Aurora Cannabis Inc. (TSE:ACB) shot up 9.9% during trading on Thursday . The stock traded as high as C$6.92 and last traded at C$6.88. 267,087 shares were traded during trading, a decline of 54% from the average session volume of 574,670 shares. The stock had previously closed at C$6.26.

Analyst Ratings Changes

Several research firms have commented on ACB. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. Atb Cap Markets raised shares of Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Finally, ATB Capital dropped their price objective on shares of Aurora Cannabis from C$11.00 to C$8.50 in a report on Tuesday, December 17th.

Aurora Cannabis Price Performance

The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 18.72. The business’s 50-day simple moving average is C$6.88 and its 200 day simple moving average is C$6.96. The firm has a market capitalization of C$349.59 million, a P/E ratio of -7.89 and a beta of 2.71.

Insider Activity

In related news, Senior Officer Andre Jerome sold 13,390 shares of the firm’s stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of C$9.30, for a total value of C$124,524.32.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.